Skip to main content

DataJoint

Category: AI in Analytics & BI

An operating platform for scientific data, computation, and analysis that helps research labs streamline, automate, and protect their research. DataJoint was founded in 2016. The company is led by Jim Olson. Based in Houston, Texas, USA. Team size: 11-50. Total funding raised: $4.9M. Latest round: Seed. Key investors include Nina Capital, Gesing Ventures, Cambridge Square Ventures.

Founded
2016
Headquarters
Houston, Texas, USA
Team size
11-50
Total funding
$4.9M

Value proposition

Harmonizes multimodal data sources and enables complex AI/ML workflows, transforming complex data into reproducible, scalable pipelines to accelerate discovery and ensure research integrity.

Products and solutions

DataJoint SciOps Platform (SaaS), DataJoint Core (Open-source framework), DataJoint Elements (Curated and modular data pipelines for neuroscience)

Unique value

DataJoint applies DevOps principles to scientific research ('SciOps'), creating standardized, automated, and reproducible workflows for complex data pipelines.

Target customer

Academic, life sciences, and pharmaceutical research labs, with a strong focus on neuroscience.

Industries served

Life Sciences, Neuroscience, Oncology, Systems Biology, Pharmaceuticals

Technology advantage

A computational database model that integrates data management with automated analysis inside the data pipeline; open-source core fosters adoption while a scalable SaaS platform provides enterprise support.

How they differentiate

Provides a comprehensive SciOps platform integrating a relational computational database with a workflow engine to ensure data integrity and reproducibility for complex scientific research.

Main competitors

Flywheel, LabKey, Benchling

Key partnerships

PharmStars (Pharma-focused global accelerator), Neurodata Without Borders (NWB), International Neuroinformatics Coordinating Facility (INCF), Academic research institutions such as Johns Hopkins University, UCSF, Harvard, and UCL

Notable customers

Johns Hopkins University, Stanford University, Baylor College of Medicine, Allen Institute for Brain Science

Major milestones

Secured $4.9M in seed funding., Served as the data and operations infrastructure for the MICrONS brain study (findings published in Nature)., Expanded platform from academic research to support commercial life sciences and pharmaceutical companies.

Growth metrics

Specific growth metrics are not publicly available.

Market positioning

Specialized, high-performance data management and analysis platform for academic and research institutions and commercial life sciences/pharma.

Geographic focus

Primarily North America and Europe

Patents and IP

No public patents were found. Core technology is built around an open-source framework.

About Jim Olson

Experienced CEO with a background in scaling technology companies in the healthcare and research sectors. Previously served as CEO at Flywheel and as CTO at West Publishing (Thomson Reuters), where he led development of Westlaw.com.

Official website: